Nikole J. Byrne

Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure

Nikole J. Byrne, Nobutoshi Matsumura, Zaid H. Maayah et al. · Circulation Heart Failure · 2020 · 254 citations · Full text

Life Sciences, Cardiology, Pharmacology +17

Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome

Miranda M. Sung, Ty T. Kim, Emmanuel Denou et al. · Diabetes · 2016 · 210 citations

Life Sciences, Microbiology, Nutritional Sciences +17

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin

Koenraad Philippaert, Subha Kalyaanamoorthy, Mohammad Fatehi et al. · Circulation · 2021 · 197 citations · Full text

Medicine, Cardiology, Pharmacology +17

Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure

Nikole J. Byrne, Shubham Soni, Shingo Takahara et al. · Circulation Heart Failure · 2020 · 100 citations · Full text

Life Sciences, Cardiology, Physiology +16

Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism

Miranda M. Sung, Subhash K. Das, Jody Levasseur et al. · Circulation Heart Failure · 2014 · 98 citations · Full text

Life Sciences, Cardiology, Physiology +16